Aligos Therapeutics (ALGS) Prepaid Assets (2019 - 2026)

Aligos Therapeutics (ALGS) has reported Prepaid Assets for 8 consecutive years, with $3.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Prepaid Assets fell 19.7% year-over-year to $3.9 million; the trailing twelve-month figure through Jun 2026 stood at $3.9 million (down 19.7% YoY), and the FY2025 full-year result was $4.9 million, down 3.61% from the prior year.
• Prepaid Assets declined to $3.9 million in Q2 2026 per ALGS's latest filing, from $4.5 million in the prior quarter.
• Across five years, Prepaid Assets topped out at $10.3 million in Q1 2022 and bottomed at $3.4 million in Q2 2023.
• Historically, Prepaid Assets has averaged $5.6 million across 5 years, with a median of $5.0 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Prepaid Assets soared 75.83% in 2022, then slumped 59.58% in 2023.
• Over 5 years, Prepaid Assets stood at $7.6 million in 2022, then tumbled by 30.16% to $5.3 million in 2023, then retreated by 4.11% to $5.1 million in 2024, then declined by 3.61% to $4.9 million in 2025, then fell by 20.01% to $3.9 million in 2026.
• According to Business Quant data, Prepaid Assets over the past three periods registered $3.9 million, $4.5 million, and $4.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.